Mindteck (India) Limited, (BSE: 517344 and NSE: MINDTECK), the global engineering and technology solutions company with niche knowledge and expertise in the storage, medical device, semiconductor and analytical instrument industries, recently announced a project win with a medical device and equipment company headquartered in the United States.
The new client, a subsidiary of an S&P 500 diversified technology company, designs medical solutions and systems that help prevent the transmission of infection. One of its areas of specialisations is highlevel disinfection systems of ultrasound probes.
The hardware reengineering project encompasses electronic and firmware design, as well as the modernisation of a user interface. The scope extends to system enhancements for integrating electrical leakage detection and thermal printing.
Mr. Jacob Pillay, Senior Vice President - Global Sales, said: "It is an honour to work alongside an esteemed company in their fight to control and prevent infection." He added, "We are excited about this strategic win, and we look forward to making a meaningful contribution and delivering a successful outcome.
Commenting on the win, Mr. Anand Balakrishnan, Chief Executive Officer and Managing Director, said: "During such a time of uncertainty, I think that it is absolutely wonderful to be rewarded for our valued niche knowledge and expertise by yet another medical device company."
Shares of MINDTECK (INDIA) LTD. was last trading in BSE at Rs.34.3 as compared to the previous close of Rs. 36.1. The total number of shares traded during the day was 2898 in over 37 trades.
The stock hit an intraday high of Rs. 34.35 and intraday low of 34.3. The net turnover during the day was Rs. 99433.